Barbara Ann Karmanos Cancer Hospital — Detroit, Michigan

Barbara Ann Karmanos Cancer Hospital is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Hospital has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Endometrial Cancer, Clear Cell Renal Cell Carcinoma, Myelodysplastic Syndromes.

Sponsors: Incyte Corporation, Telix Pharmaceuticals (Innovations) Pty Limited, Incyte Biosciences International Sàrl.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Hospital?

Barbara Ann Karmanos Cancer Hospital has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Hospital conducted?

Barbara Ann Karmanos Cancer Hospital has 9 clinical trials on record, with 5 currently active. Their work covers Endometrial Cancer, Clear Cell Renal Cell Carcinoma, Myelodysplastic Syndromes.

Is Barbara Ann Karmanos Cancer Hospital accredited by Crixeo Health?

Barbara Ann Karmanos Cancer Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.